Schering, IBA ink radiopharma deal

Feb 22, 2006

German contrast media firm Schering said that its French subsidiary, Schering S.A.S., will transfer the radiopharmaceutical business of CIS bio international to a consortium formed by Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, and the Institut National des Radioéléments of Walloon, Belgium.

As part of the transaction, the IBA consortium acquires Berlin-based Schering's current radiopharmaceutical business. The deal is expected to close within the first half of 2006, Schering said.

Although terms of the deal were not released, Schering said that the transaction will have a negative one-time effect of approximately euro 50 million ($59.6 million U.S.) on its operating profit for fiscal year 2006.

By AuntMinnie.com staff writers
February 23, 2006

Schering may sell CIS bio radiopharma unit, December 5, 2005

Schering partners with Philips, Siemens, November 29, 2005

Schering, Epix score European approval for Vasovist, October 5, 2005

EU regulators recommend approving Schering imaging agent, June 28, 2005

$ChatGPT powered by GPT-4 and using DALL-E−3 was asked to generate an image for teaching purposes that demonstrated: a nuclear medicine bone scan with skeletal metastases (top left); coronary artery disease (top right); an F-18 FDG-PET scan of the brain with Alzheimer's disease (bottom left); and an x-ray showing a fracture (bottom right). These are misleading for educational purposes and for patients who may be searching for information. Image and caption courtesy of Radiography.$